Canada Pension Plan Investment Board
BDTX icon

Canada Pension Plan Investment Board’s Black Diamond Therapeutics BDTX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$192K Sell
103,600
-107,800
-51% -$264K ﹤0.01% 1607
2026
Q1 		$450K Buy
211,400
+8,300
+4% +$19.7K ﹤0.01% 1273
2025
Q4 		$494K Buy
+203,100
New +$719K ﹤0.01% 1307

Other funds holding BDTX

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Canada Pension Plan Investment Board's BDTX Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Black Diamond Therapeutics (BDTX) stake by 51% in Q2 2026, selling an estimated $264K and leaving 103,600 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #1607.

Canada Pension Plan Investment Board first reported a position in BDTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $494K in Q4 2025. 96 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • Canada Pension Plan Investment Board held 103,600 shares of Black Diamond Therapeutics worth $192K as of Q2 2026.
  • Canada Pension Plan Investment Board sold 107,800 Black Diamond Therapeutics shares in Q2 2026, an estimated $264K.
  • Black Diamond Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1607 holding.
  • Canada Pension Plan Investment Board first reported a position in Black Diamond Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Canada Pension Plan Investment Board's Black Diamond Therapeutics position peaked at $494K in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.